Scientific work

Prof. Dr. Vahit Özmen

883 publications. The source of the information is stated next to each publication.

Back to profile

  1. 46.Shyyan R, Masood S, Badwe RA, Errico KM, Liberman L, Ozmen V, Stalsberg H, Vargas H, Vass L; for the Global Summit Diagnosis and Pathology Panel. Breast cancer in limited-resource countries: diagnosis and pathology. Breast J. 2006 Jan-Feb;12 Suppl 1:S27-37.

    Source: florence.com.tr profile page

  2. 47.Ozmen V: Laparoscopic cholecystectomy for gangrenous cholecytitis in the elderly- Reply. J Laparoendosc Adv Surg Tech A. 16 (1):80-80, 2006.

    Source: florence.com.tr profile page

  3. 48.Sanli Y, Berberoglu K, Turkmen C, Ozmen V, Muslumanoglu M, Igci A, Asoglu O, Kecer M, Tuzlali S, Cantez S, Mudun A. The Value of Combined Peritumoral and Subdermal Injection Techniques for Lymphoscintigraphy in Detection of Sentinel Lymph Node in Breast Cancer.Clin Nucl Med. 2006 Nov;31(11):690-693.

    Source: florence.com.tr profile page

  4. 49.Ozmen V, Cabioglu N. Sentinel lymph node biopsy for breast cancer: Current Controversies. Breast J. 2006 Sep-Oct;12(5 Suppl 2):S134-42. Review.

    Source: florence.com.tr profile page

  5. 50.Ozmen V, Asoglu O, Karanlik H, Cabioglu N, Kecer M, Bakkaloglu H. Primary ovarian cancer presenting with axillary lymph node metastases: a report of two cases. Acta Chir Belg. 2007 Jan-Feb;107(1):75-7.

    Source: florence.com.tr profile page

  6. 51.Ozcinar B, Ozmen V. Superior vena cava syndrome after subclavian vein chemotherapy port replacement in a patient with breast cancer. Breast J. 2007 Jul-Aug;13(4):425-6. PMID: 17593052 [PubMed - in process]

    Source: florence.com.tr profile page

  7. 52. Sen-Oran E, Ozmen V, Bilir A, Cabioglu N, Muslumanoglu M, Igci A, Guney N, Kecer M. Is the thymidine labeling index a good prognostic marker in breast cancer? World J Surg Oncol. 2007 Aug 19;5:93.

    Source: florence.com.tr profile page

  8. 53.Asoglu O, Karanlik H, Muslumanoglu M, Igci A, Emek E, Ozmen V, Kecer M, Parlak M, Kapran Y. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: A single institute experience. Eur J Surg Oncol. 33(10):1199-206, 2007.

    Source: florence.com.tr profile page

  9. 54.Mudun A, Sanli Y, Ozmen V, Turkmen C, Ozel S, Eroglu A, Igci A, Yavuz E, Tuzlali S, Muslumanoglu M, Cantez S. Comparison of different injection sites of radionuclide for sentinel lymph node detection in breast cancer: single institution experience. Clin Nucl Med. 2008 Apr;33(4):262-7.

    Source: florence.com.tr profile page

  10. 55.Derin D, Eralp Y, Ozluk Y, Yavuz E, Guney N, Saip P, Igci A, Ozmen V, Kucucuk S, Aslay I, Aydiner A, Topuz E. Lower Level of MAPK Expression is Associated with Anthracycline Resistance and Decreased Survival in Patients with Hormone Receptor Negative Breast Cancer. Cancer Invest. 2008 Jun 14:1.

    Source: florence.com.tr profile page

  11. 56.Yip CH, Smith RA, Anderson BO, Miller AB, Thomas DB, Ang ES, Caffarella RS, Corbex M, Kreps GL, McTiernan A, Anyanwu S, Cabioglu N, Kovtun A, Murillo R, Myakynkov V, Nyström L, Ozmen V, Remennick L, Russell C, Sener SF, Sepulveda C, Shastri S, Smith RA, Thomas D, Yip CH.; Breast Health Global Initiative Early Detection Panel. Guideline implementation for breast healthcare in low- and middle-income countries: early detection resource allocation. Cancer. 2008 Oct 15;113(8 Suppl):2244-56.

    Source: florence.com.tr profile page

  12. 57.Cabioglu N, Ozmen V, Kaya H, Tuzlali S, Igci A, Muslumanoglu M, Kecer M, Dagoglu T. Increased lymph node positivity in multifocal and multicentric breast cancer. J Am Coll Surg. 2009 Jan;208(1):67-74. Epub 2008 Oct 31.

    Source: florence.com.tr profile page

  13. 58.Ozmen V, Anderson BO. The Challenge of Breast Cancer in Low- and Middle-income Countries—Implementing the Breast Health Global Initiative Guidelines. US Oncology 2008, 76-79.

    Source: florence.com.tr profile page

  14. 59.Asoglu O, Matlim T, Karanlik H, Atar M, Muslumanoglu M, Kapran Y, Igci A, Ozmen V, Kecer M, Parlak M. Impact of laparoscopic surgery on bladder and sexual function after total mesorectal excision for rectal cancer. Surg Endosc. 2009 Feb 23(2):296-303.

    Source: florence.com.tr profile page

  15. 60.Ozmen V, Ozcinar B, Karanlik H, Cabioglu N, Tukenmez M, Disci R, Ozmen T, Igci A, Muslumanoglu M, Kecer M, Soran A. Breast cancer risk factors in Turkish women--a University Hospital based nested case control study. World J Surg Oncol. 2009 Apr 8;7:37.

    Source: florence.com.tr profile page

  16. 61. Ozmen V, Ozkan Gurdal S, Muslumanoglu M, Igci A, Tuzlali SS, Ozcinar B, Canbay E, Kecer M, Dagoglu T. Predictive factor for residual tumor after lumpectomy for close margins. J Clin Oncol. 2009 May 20;27(15_suppl):e11538. PMID: 27964684

    Source: florence.com.tr profile page

  17. 62. Ozcinar B, Ozmen V, Guler SA, Gulluoglu BM, Kocaman N, Ozkan M, Muslumanoglu ME, Igci A, Kecer M, Dagoglu T. Complications of local/regional treatment of breast cancer and quality of life. J Clin Oncol. 2009 May 20;27(15_suppl):e11597. PMID: 27964213

    Source: florence.com.tr profile page

  18. 63.Asoglu O, Karanlik H, Parlak M, Kecer M, Muslumanoglu M, Igci A, Ozmen V, Gulluoglu M, Kapran Y. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer. Hepatogastroenterology. 2009 May-Jun;56(91-92):908-13.

    Source: florence.com.tr profile page

  19. 64.Gur AS, Unal B, Ozbek U, Ozmen V, Aydogan F, Gokgoz S, Gulluoglu BM, Aksaz E, Ozbas S, Baskan S, Koyuncu A, Soran A; For the Turkish Federation of Breast Disease Associations Protocol MF08-01 investigators. Validation of breast cancer nomograms for predicting the non-sentinel lymph node metastases after a positive sentinel lymph node biopsy in a multi-center study. Eur J Surg Oncol 2010 Jan; 36(1):30-5.

    Source: florence.com.tr profile page

  20. 65.Ozmen V, Unal ES, Muslumanoglu ME, Igci A, Canbay E, Ozcinar B, Mudun A, Tunaci M, Tuzlali S, Kecer M. Axillary sentinel node biopsy after neoadjuvant chemotherapy. Eur J Surg Oncol. 2010 Jan;36(1):23-9.

    Source: florence.com.tr profile page

  21. 66.Ozcinar B, Muslumanoglu M, Igci A, Gurdal SO, Yavuz E, Kecer M, Dagoglu T, Ozmen V. Clinical importance of micrometastasis in sentinel lymph nodes. Breast. 2010 Sep 20(1):31-3.

    Source: florence.com.tr profile page

  22. 67.Ozmen V, Nilufer Ozaydin A, Cabioglu N, Gulluoglu BM, Unalan PC, Gorpe S, Oner BR, Aribal E, Thomas DB, Anderson BO. 2.Survey on a mammographic screening program in Istanbul, Turkey. Breast J. 2011 May-Jun;17(3):260-7.

    Source: florence.com.tr profile page

  23. 68.Keskin S, Muslumanoglu M, Saip P, Karanlık H, Guveli M, Pehlivan E, Aydoğan F, Eralp Y, Aydıner A, Yavuz E, Ozmen V, Igci A, Topuz E. Clinical and pathological features of breast cancer associated with the pathological complete response to anthracycline-based neoadjuvant chemotherapy.Oncology; 2011;81(1):30-8.

    Source: florence.com.tr profile page

  24. 69.Uskent N, Cokmez A, Atahan MK, Aksaz E, Guler N, Muslumanoglu M, Ozmen V. An electronic non-interventional pharmacovigilance study of early-stage breast cancer patients on adjuvant treatment with anastrozole (Arimidex®). Turkish Journal of Oncology; 2011, 26:55-60.

    Source: florence.com.tr profile page

  25. 70.Eryilmaz MA, Muslumanoglu M, Ozmen V, Igci A, Koc M. Breast conserving surgery in patients with multifocal/multicentric breast cancer. J BUON. 2011 Jul-Sep;16(3):450-3.

    Source: florence.com.tr profile page

  26. 71.Ozbas S, Ozmen V, Igci A, Muslumanoglu M, Ozcinar B, Balkan M, Aydogan F, Canda T, Harmancioglu O, Aksaz E, Gulluoglu BM, Kayahan M, Ozaslan C, Canturk NZ, Mersin H, Utkan Z, Kocak S, Ulufi N, Polat AK, Andacoglu O, Soran A.Predicting the Likelihood of Nonsentinel Lymph Node Metastases in Triple Negative Breast Cancer Patients With a Positive Sentinel Lymph Node: Turkish Federation of Breast Disease Associations Protocol MF09-01. Clin Breast Cancer. 2012; 12:63-67.

    Source: florence.com.tr profile page

  27. 72.Gurdal SO, Ozcinar B, Kayahan M, Igci A, Tunaci M, Ozmen V, Acunas G, Yavuz E, Kecer M, Muslumanoglu M. The incremental value of magnetic resonance imaging for breast surgery planning. Surg Today. 2012

    Source: florence.com.tr profile page

  28. 73.Eralp Y, Keskin S, Akşk E, Iğci A, Müslümanoğlu M, Ylmaz S, Tunac M, Camlca H, Tuzlal S, Saip P, Dalay N, Ozmen V, Topuz E.Predictive Role of Midtreatment Changes in Survivin, GSTP1, and Topoisomerase 2α Expressions for Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer. Am J Clin Oncol. 2012

    Source: florence.com.tr profile page

  29. 74.Eryilmaz MA, Igci A, Muslumanoglu M, Ozmen V, Koc M. Male breast cancer: a retrospective study of 15 years. J BUON. 2012

    Source: florence.com.tr profile page

  30. 75.Gurdal SO, Karanlik H, Cabioglu N, Ozcinar B, Yavuz E, Tuzlali S, Ozmen V. Positive or close margins in breast conserving surgery: Is re-excision always necessary? Eur J Surg Oncol. 2012 May;38(5):399-406. Epub 2012 Mar 21.PMID:22440741

    Source: florence.com.tr profile page

  31. 76.Ozcinar B, Guler SA, Kocaman N, Ozkan M, Gulluoglu BM, Ozmen V. Breast cancer related lymphedema in patients with different loco-regional treatments. Breast. 2012 Jun;21(3):361-5. doi: 10.1016/j.breast.2012.03.002. Epub 2012 Mar 27.

    Source: florence.com.tr profile page

  32. 77.Gurdal SO, Kostanoglu A, Cavdar I, Ozbas A, Cabioglu N, Ozcinar B, Igci A, Muslumanoglu M, Ozmen V. Comparison of intermittent pneumatic compression with manual lymphatic drainage for treatment of breast cancer-related lymphedema. Lymphat Res Biol. 2012 Sep;10(3):129-35. doi: 10.1089/lrb.2012.0002.PMID: 22984910 [PubMed - in process].

    Source: florence.com.tr profile page

  33. 78.Ugur S, Arıcı C, Yaprak M, Mescı A, Arıcı GA, Dolay K, Ozmen V. Risk factors of breast cancer-related lymphedema. Lymphat Res Biol. 2013 Jun;11(2):72-5. doi: 10.1089/lrb.2013.0004. PMID: 23772716

    Source: florence.com.tr profile page

  34. 79.Jassem J, Ozmen V, Bacanu F, Drobniene M, Eglitis J, Lakshmaiah KC, Kahan Z, Mardiak J, Pienkowski T, Semiglazova T, Stamatovic L, Timcheva C, Vasovic S, Vrbanec D, Zaborek P. Delays in diagnosis and treatment of breast cancer: a multinational analysis. Eur J Public Health. 2014 Oct;24(5):761-7. doi: 10.1093/eurpub/ckt131. PMID: 24029456

    Source: florence.com.tr profile page

  35. 80.Tukenmez M, Ozden BC, Agcaoglu O, Kecer M, Ozmen V, Muslumanoglu M, Igci A. Videoendoscopic Single-Port Nipple-Sparing Mastectomy and Immediate Reconstruction. J Laparoendosc Adv Surg Tech A. 2014 Feb;24(2):77-82. doi: 10.1089/lap.2013.0172. Epub 2014 Jan 8.PMID: 24401140

    Source: florence.com.tr profile page

  36. 81.Ozdemir F, Koksal M, Ozmen V, Aydin I, Buyru N. Mutations and Krüppel-like factor 6 (KLF6) expression levels in breast cancer. Tumour Biol. 2014 Feb 12. PMID: 24519062 [PubMed - as supplied by publisher]

    Source: florence.com.tr profile page

  37. 82. Ozkan-Gurdal S, Cabioglu N, Ozcinar B, Muslumanoglu M, Ozmen V, Kecer M, Yavuz E, Igci A. Factors Predicting Microinvasion in Ductal Carcinoma in situ. Asian Pac J Cancer Prev. 2014;15(1):55-60. PMID: 24528005 [PubMed - in process]

    Source: florence.com.tr profile page

  38. 83. Alco G, Igdem S, Dincer M, Ozmen V, Saglam S, Selamoglu D, Erdogan Z, Ordu C, Pilanci KN, Bozdogan A, Yenice S, Tecimer C, Demir G, Koksal G, Okkan S. Vitamin D levels in patients with breast cancer: importance of dressing style. Asian Pac J Cancer Prev. 2014;15(3):1357-62.

    Source: florence.com.tr profile page

  39. 84. Kayhan A, Gurdal SO, Ozaydin N, Cabioglu N, Ozturk E, Ozcinar B, Aribal E, Ozmen V. Successful first round results of a Turkish breast cancer screening program with mammography in bahcesehir, istanbul. Asian Pac J Cancer Prev. 2014;15(4):1693-7.

    Source: florence.com.tr profile page

  40. 85. Agacayak F, Ozturk A, Bozdogan A, Selamoglu D, Alco G, Ordu C, Pilanci KN, Killi R, Ozmen V. Stereotactic vacuum-assisted core biopsy results for non- palpable breast lesions. Asian Pac J Cancer Prev. 2014;15(13):5171-4. PMID: 25040970

    Source: florence.com.tr profile page

  41. 86. Ozmen V, Boylu S, Ok E, Canturk NZ, Celik V, Kapkac M, Girgin S, Tireli M, Ihtiyar E, Demircan O, Baskan MS, Koyuncu A, Tasdelen I, Dumanli E, Ozdener F, Zaborek P.Factors affecting breast cancer treatment delay in Turkey: a study from Turkish Federation of Breast Diseases Societies. Eur J Public Health. 2015 Feb;25(1):9-14. doi: 10.1093/eurpub/cku086. Epub 2014 Aug 5. PMID: 25096257

    Source: florence.com.tr profile page

  42. 87. Tukenmez M, Agcaoglu O, Aksakal N, Destek S, Cabioglu N, Barbaros U, Erbil Y, Bozbora A, Dinccag A, Ozmen V, Muslumanoglu M, Igci A . The use of ligasure vessel sealing system in axillary dissection; effect on seroma formation.. Chirurgia (Bucur). 2014 Sep-Oct;109(5):620-5.

    Source: florence.com.tr profile page

  43. 88.Erdogan Iyigun Z, Selamoglu D, Alco G, Pilancı KN, Ordu C, Agacayak F, Elbüken F, Bozdogan A, Ilgun S, Guler Uysal F, Ozmen V. Bioelectrical Impedance for Detecting and Monitoring Lymphedema in Patients with Breast Cancer. Preliminary Results of the Florence Nightingale Breast Study Group. Lymphat Res Biol. 2015 Mar;13(1):40-5. doi: 10.1089/lrb.2014.0014. Epub 2014 Dec 19. PMID: 25526543

    Source: florence.com.tr profile page

  44. 89. Alco G, Bozdogan A, Selamoglu D, Pilanci KN, Tuzlali S, Ordu C, Igdem S, Okkan S, Dincer M, Demir G, Ozmen V. Clinical and histopathological factors associated with Ki-67 expression in breast cancer patients. Oncol Lett. 2015 Mar;9(3):1046-1054. Epub 2015 Jan 7. PMID: 25663855

    Source: florence.com.tr profile page

  45. 90. Pilanci KN, Alco G, Ordu C, Sarsenov D, Celebi F, Erdogan Z, Agacayak F, Ilgun S, Tecimer C, Demir G, Eralp Y, Okkan S, Ozmen V. Is administration of trastuzumab an independent risk factor for developing osteonecrosis of the jaw among metastatic breast cancer patients under zoledronic Acid treatment? Medicine (Baltimore). 2015 May;94(18):e671. doi: 10.1097/MD.0000000000000671. PMID: 25950681

    Source: florence.com.tr profile page

  46. 91. Ozmen V, Ozcinar B, Bozdogan A, Eralp Y, Yavuz E, Dincer M. The effect of internal mammary lymph node biopsy on the therapeutic decision and survival of patients with breast cancer. Eur J Surg Oncol. 2015 Jul 16. pii: S0748-7983(15)00528-4. doi: 10.1016/j.ejso.2015.07.005. [Epub ahead of print] PMID: 26210653

    Source: florence.com.tr profile page

  47. 92.Celebi F, Pilancı KN, Ordu Ç, Ağacayak F, Alço G, İlgün S, Sarsenov D, Erdoğan Z, Ozmen V. The role of ultrasonographic findings to predict molecular subtype, histologic grade, and hormone receptor status of breast cancer. Diagn Interv Radiol. 2015 Nov-Dec;21(6):448-53. doi: 10.5152/dir.2015.14515.

    Source: florence.com.tr profile page

  48. 93.McCormack VA, Burton A, Dos-Santos-Silva , Hipwell JH, Dickens C, Salem D, Kamal R, Hartman M, Lee CP, Chia KS, Ozmen V, Aribal ME, Flugelman AA, Lajous M, Lopez-Riduara R, Rice M, Romieu I, Ursin G, Qureshi S, Ma H, Lee E, van Gils CH, Wanders JO, Vinayak S, Ndumia R, Allen S, Vinnicombe S, Moss S, Won Lee J, Kim J, Pereira A, Garmendia ML, Sirous R, Sirous M, Peplonska B, Bukowska A, Tamimi RM, Bertrand K, Nagata C, Kwong A, Vachon C, Scott C, Perez-Gomez B, Pollan M, Maskarinec G, Giles G, Hopper J, Stone J, Rajaram N, Teo SH, Mariapun S, Yaffe MJ, Schüz J, Chiarelli AM, Linton L, Boyd NF. . International Consortium on Mammographic Density: Methodology and population diversity captured across 22 countries.Cancer Epidemiol. 2015 Dec 24;40:141-151. doi: 10.1016/j.canep.2015.11.015. [Epub ahead of print]

    Source: florence.com.tr profile page

  49. 94.Ozmen V, Atasoy A, Gokmen E, Ozdogan M, Guler N, Uras C, Ok E, Demircan O, Isikdogan A, Saip P. Impact of Oncotype DX Recurrence Score on Treatment Decisions: Results of a Prospective Multicenter Study in Turkey. Cureus. 2016 Mar 8;8(3):e522. doi: 10.7759/cureus.522. PMID: 27081583 Free PMC Article

    Source: florence.com.tr profile page

  50. 95.Ordu C, McGuire K, Alco G, Nur Pilanci K, Koksal UI, Elbüken F, Erdogan Z, Agacayak F, Ilgun S, Sarsenov D, Öztürk A, İğdem Ş, Okkan S, Eralp Y, Dincer M, Ozmen V. The Prognostic Impact of Molecular Subtypes and Very Young Age on Breast Conserving Surgery in Early Stage Breast Cancer. Cureus. 2016 Jun 7;8(6):e633. doi: 10.7759/cureus.633. PMID: 27433412 Free PMC Article

    Source: florence.com.tr profile page